试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
1920×1080
www.fiercepharma.com
Fierce 50 of 2024 | Fierce Pharma
2143×1206
www.fiercepharma.com
Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal | Fierce Pharma
1280×720
www.fiercepharma.com
GSK pumps £200M+ into UK manufacturing network to bolster commercial ambitions, API supply ...
5760×3240
www.fiercepharma.com
Bristol Myers Squibb's Karuna buyout pays off with FDA approval for novel schizophr…
1370×913
www.fiercepharma.com
UPDATED: As Stelara cliff looms, J&J expects 25 blockbuster drugs …
4500×3000
www.fiercepharma.com
Takeda details another round of layoffs in Massachusetts as restru…
1280×768
www.fiercepharma.com
CDC probes possible safety risk for Pfizer's new COVID shot, sees no nee…
2121×1414
www.fiercepharma.com
Johnson & Johnson accuses former employee of taking thousands of file…
1024×683
www.fiercepharma.com
India's Lupin recalls more than 600K bottles of blood pressure med for qu…
2000×1125
www.fiercepharma.com
Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy product…
5671×4063
www.fiercepharma.com
Eisai, Biogen's Leqembi to haul in $12.9B through 2028: report
2309×1299
www.fiercepharma.com
Dr. Reddy's pulls more than 300K bottles of thyroid drug citing presence of a car…
2193×1233
www.fiercepharma.com
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer | Fierc…
1920×1281
www.fiercepharma.com
Navigating the Impact of the Inflation Reduction Act: Assessi…
1280×726
www.fiercepharma.com
Novartis expands Pluvicto manufacturing footprint with FDA blessing of Indianap…
2309×1299
www.fiercepharma.com
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead | Fierce Pharma
2121×1198
www.fiercepharma.com
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
1280×732
www.fiercepharma.com
In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use ...
2121×1414
www.fiercepharma.com
Olympus mounts lung cancer education push with advocacy gro…
1280×720
www.fiercepharma.com
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal canc…
2059×1456
www.fiercepharma.com
Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutti…
1948×1095
www.fiercepharma.com
Omnicom, Interpublic ink merger to create world’s largest ad agency | Fierce Pharma
1920×1080
www.fiercepharma.com
Endo takes a hands-on approach to new Dupuytren's contracture ad
2000×1125
www.fiercepharma.com
Kenvue maps out hundreds of layoffs as service pact with J&J winds down | Fierce Pharma
1280×720
www.fiercepharma.com
After short FTC fight, Amgen wraps up $27.8B Horizon buyout | Fierce Pharma
1280×720
www.fiercepharma.com
Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocomp…
1280×720
www.fiercepharma.com
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approv…
724×482
www.fiercepharma.com
Marinus cuts 45% of staff after key medicine stumbled in pair of pha…
2208×1351
www.fiercepharma.com
Analysts tip label expansion to bolster GSK's hand in RSV fight
1280×721
www.fiercepharma.com
Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug ...
1280×726
www.fiercepharma.com
Sanofi moves on J&J in first-line myeloma with FDA nod
1280×720
www.fiercepharma.com
Roche's Vabysmo shows an edge over Eylea in retina drying
1920×1080
www.fiercepharma.com
Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking ...
1280×726
www.fiercepharma.com
High-flying Eli Lilly plots $15B share buyback campaign | Fierce Pharma
1280×727
www.fiercepharma.com
As former BMS CEO Giovanni Caforio plots move to Novartis, will noncompete issues come into play?
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈
反馈
